Guggenheim Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,267
Closed -$118K 1838
2025
Q3
$118K Buy
+15,267
New +$119K ﹤0.01% 1549
2025
Q2
Sell
-21,784
Closed -$173K 1669
2025
Q1
$173K Sell
21,784
-3,393
-13% -$34.3K ﹤0.01% 1555
2024
Q4
$229K Sell
25,177
-12,031
-32% -$116K ﹤0.01% 1542
2024
Q3
$342K Buy
37,208
+1,246
+3% +$10.3K ﹤0.01% 1559
2024
Q2
$352K Sell
35,962
-3,968
-10% -$48.4K ﹤0.01% 1589
2024
Q1
$603K Buy
39,930
+6,158
+18% +$112K ﹤0.01% 1398
2023
Q4
$728K Sell
33,772
-4,287
-11% -$79.1K 0.01% 1298
2023
Q3
$708K Buy
38,059
+14,909
+64% +$348K 0.01% 1260
2023
Q2
$586K Buy
23,150
+2,587
+13% +$65.1K ﹤0.01% 1399
2023
Q1
$533K Buy
20,563
+9,482
+86% +$254K ﹤0.01% 1471
2022
Q4
$262K Sell
11,081
-6,748
-38% -$182K ﹤0.01% 1708
2022
Q3
$452K Buy
17,829
+151
+0.9% +$5.3K ﹤0.01% 1520
2022
Q2
$587K Buy
17,678
+2,475
+16% +$105K ﹤0.01% 1503
2022
Q1
$1.1M Sell
15,203
-1,260
-8% -$90.8K 0.01% 1317
2021
Q4
$1.51M Buy
16,463
+4,529
+38% +$541K 0.01% 1192
2021
Q3
$1.51M Buy
11,934
+2,299
+24% +$335K 0.01% 1193
2021
Q2
$1.6M Buy
9,635
+230
+2% +$37.3K 0.01% 1229
2021
Q1
$1.71M Buy
9,405
+1,427
+18% +$331K 0.01% 1117
2020
Q4
$1.59M Buy
7,978
+5,922
+288% +$1.2M 0.01% 1081
2020
Q3
$451K Sell
2,056
-1,162
-36% -$246K ﹤0.01% 1484
2020
Q2
$614K Sell
3,218
-178
-5% -$31.2K ﹤0.01% 1384
2020
Q1
$527K Sell
3,396
-1,488
-30% -$173K 0.01% 1350
2019
Q4
$409K Buy
4,884
+317
+7% +$24.1K ﹤0.01% 1672
2019
Q3
$309K Sell
4,567
-2,301
-34% -$151K ﹤0.01% 1834
2019
Q2
$456K Sell
6,868
-1,798
-21% -$105K ﹤0.01% 1699
2019
Q1
$482K Sell
8,666
-344
-4% -$21K ﹤0.01% 1698
2018
Q4
$447K Buy
+9,010
New +$551K ﹤0.01% 1731
2018
Q2
Sell
-7,780
Closed -$315K 2581
2018
Q1
$315K Sell
7,780
-44
-0.6% -$1.66K ﹤0.01% 2522
2017
Q4
$272K Buy
+7,824
New +$260K ﹤0.01% 2518

Other funds holding TDOC